Title: Prediction of thyroid C-cell carcinogenicity after chronic administration of GLP1-R agonists in rodents.
Journal: Toxicology and applied pharmacology 20170401
Title: Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia.
Journal: Regulatory peptides 20130810
Title: Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).
Journal: Diabetes, obesity & metabolism 20121001
Title: [Basal insulin and GLP-1 agonist potentiate each other (interview by Dr. med Dirk Einecke)].
Journal: MMW Fortschritte der Medizin 20120628
Title: Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).
Journal: Diabetes care 20120601
Title: Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis.
Journal: BMC neuroscience 20120101
Title: Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis.
Journal: Experimental diabetes research 20120101
Title: Lixisenatide for type 2 diabetes mellitus.
Journal: Expert opinion on investigational drugs 20110401
Title: Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes.
Journal: Regulatory peptides 20100924
Title: Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20100901
Title: Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.
Journal: IDrugs : the investigational drugs journal 20090801
Title: Preclinical pharmacology of the new GLP-1 receptor agonist AVE0010.
Journal: Annales d'endocrinologie 20080401
Title: Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.
Journal: The Journal of pharmacology and experimental therapeutics 20031101
Title: Ahrén B et al. Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis. Diabetes Ther. 2016 Jun 18
Title: Lorenz M, et al. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia. Regul Pept. 2013 Aug 10;185:1-8.
